Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > HLA-DRA(Gene name) > Human
  • Add your favorite
  • HLA-DRA (Gene name),
  • HLA class II histocompatibility antigen, DR alpha chain (Protein name ),  DRA_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    HLA-DRA(HLA-DRA1);
    Protein name:
    HLA class II histocompatibility antigen, DR alpha chain;
    Alternative:
    MHC class II antigen DRA;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmic reticulum (ER) it forms an heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariant chain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoes sequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHC class II molecule interacts with HLA_DM, and HLA_DO in B cells, in order to release CLIP and facilitate the binding of antigenic peptides.
    Function:
    Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accomodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form an heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal miroenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading.
    Subcellular Location:
    Cell membrane Single-pass type I membrane protein Endoplasmic reticulum membrane Single-pass type I membrane protein Golgi apparatus trans-Golgi network membrane Single-pass type I membrane protein Endosome membrane Single-pass type I membrane protein Lysosome membrane Single-pass type I membrane protein Late endosome membrane Single-pass type I membrane protein The MHC class II complex transits through a number of intracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation.
    Protein Attributes:
    Sequence length:
    254
    Sequence:
    50:
    MAISGVPVLG | FFIIAVLMSA | QESWAIKEEH | VIIQAEFYLN | PDQSGEFMFD | 
    100:
    FDGDEIFHVD | MAKKETVWRL | EEFGRFASFE | AQGALANIAV | DKANLEIMTK | 
    150:
    RSNYTPITNV | PPEVTVLTNS | PVELREPNVL | ICFIDKFTPP | VVNVTWLRNG | 
    200:
    KPVTTGVSET | VFLPREDHLF | RKFHYLPFLP | STEDVYDCRV | EHWGLDEPLL | 
    250:
    KHWEFDAPSP | LPETTENVVC | ALGLTVGLVG | IIIGTIFIIK | GVRKSNAAER | 
    254:
    RGPL
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    SMR:
    Pfam:
    String:
    UniGene:
    MIM:
    KEGG:
    Uniprot:
     
    FOR
    ELISA Kit for Human HLA class II histocompatibility antigen, DR alpha chain
    CLIA Kit for Human HLA class II histocompatibility antigen, DR alpha chain
    Polyclonal Antibody for Human HLA class II histocompatibility antigen, DR alpha chain
    Monoclonal Antibody for Human HLA class II histocompatibility antigen, DR alpha chain
    Protein for Human HLA class II histocompatibility antigen, DR alpha chain

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Sequence of an HLA-DR alpha-chain cDNA clone and intron-exon organization of the corresponding gene."
      Lee J.S. , Trowsdale J. , Travers P.J. , Carey J. , Grosveld F. , Jenkins J. , Bodmer W.F.
      Nature299:750-752(1982) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRA*01:01)
    2. 2.
      "Cloning the heavy chain of human HLA-DR antigen using synthetic oligodeoxyribonucleotides as hybridization probes."
      Kajimura Y. , Toyoda H. , Sato M. , Miyakoshi S. , Kaplan S.A. , Ike Y. , Goyert S.M. , Silver J. , Hawke D. , Shively J.E. , Suggs S.V. , Wallace R.B. , Itakura K.
      DNA2:175-182(1983) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRA*01:01)
    3. 3.
      "Organization of the transcriptional unit of a human class II histocompatibility antigen: HLA-DR heavy chain."
      Schamboeck A. , Korman A.J. , Kamb A. , Strominger J.L.
      Nucleic Acids Res.11:8663-8675(1983) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DRA*01:02)
    4. 4.
      "Structure and nucleotide sequence of the heavy chain gene of HLA-DR."
      Das H.K. , Lawrance S.K. , Weissman S.M.
      Proc. Natl. Acad. Sci. U.S.A.80:3543-3547(1983) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DRA*01:01)
    5. 5.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ERRATUM;SEQUENCE REVISION
    6. 6.
      "Rapid nonlysosomal degradation of assembled HLA class II glycoproteins incorporating a mutant DR alpha-chain."
      Koppelman B. , Cresswell P.
      J. Immunol.145:2730-2736(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DRA*01:02)
    7. 7.
      "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)."
      Ebert L. , Schick M. , Neubert P. , Schatten R. , Henze S. , Korn B.
      Submitted (2004-06) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DRA*01:01)
    8. 8.
      "The DNA sequence and analysis of human chromosome 6."
      Mungall A.J. , Palmer S.A. , Sims S.K. , Edwards C.A. , Ashurst J.L. , Wilming L. , Jones M.C. , Horton R. , Hunt S.E. , Scott C.E. , Gilbert J.G.R. , Clamp M.E. , Bethel G. , Milne S. , Ainscough R. , Almeida J.P. , Ambrose K.D. , Andrews T.D. , more...
      Nature425:805-811(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELES DRA*01:01 AND DRA*01:02)
    9. 9.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE DRA*01:01)
    10. 10.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELES DRA*01:01 AND DRA*01:02)
      tissue: Blood.
      tissue: Colon.
    11. 11.
      "Primary structure of class II human histocompatibility antigens. 2nd Communication. Amino acid sequence of the N-terminal 179 residues of the alpha-chain of an HLA-Dw2/DR2 alloantigen."
      Yang C.-Y. , Kratzin H. , Gotz H. , Thinnes F.P. , Kruse T. , Egert G. , Pauly E. , Kolbel S. , Wernet P. , Hilschmann N.
      Hoppe-Seyler's Z. Physiol. Chem.363:671-676(1982) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 26-204
    12. 12.
      "N-terminal amino acid sequences of the alpha and beta chains of HLA-DR1 and HLA-DR2 antigens."
      Walker L.E. , Hewick R. , Hunkapiller M.W. , Hood L.E. , Dreyer W.J. , Reisfeld R.A.
      Biochemistry22:185-188(1983) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 26-94
      tissue: B-cell.
    13. 13.
      "Alpha chain of HLA-DR transplantation antigens is a member of the same protein superfamily as the immunoglobulins."
      Larhammar D. , Gustafsson K. , Claesson L. , Bill P. , Wiman K. , Schenning L. , Sundelin J. , Widmark E. , Peterson P.A. , Rask L.
      Cell30:153-161(1982) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 26-60;NUCLEOTIDE SEQUENCE [MRNA] OF 32-202 AND 204-254
    14. 14.
      "The amino acid sequence and gene organization of the heavy chain of the HLA-DR antigen: homology to immunoglobulins."
      Korman A.J. , Auffray C. , Schamboeck A. , Strominger J.L.
      Proc. Natl. Acad. Sci. U.S.A.79:6013-6017(1982) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-254 (ALLELE DRA*01:02)
    15. 15.
      "The HLA-DRA*0102 allele: correct nucleotide sequence and associated HLA haplotypes."
      Kralovicova J. , Marsh S.G. , Waller M.J. , Hammarstrom L. , Vorechovsky I.
      Tissue Antigens60:266-267(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 205-254 (ALLELE DRA*01:02)
      tissue: Blood.
    16. 16.
      "Heterozygote advantage for HLA class-II type in hepatitis B virus infection."
      Thursz M.R. , Thomas H.C. , Greenwood B.M. , Hill A.V.S.
      Nat. Genet.17:11-12(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN SUSCEPTIBILITY TO HBV INFECTION
    17. 17.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ERRATUM
    18. 18.
      "Invariant chain structure and MHC class II function."
      Cresswell P.
      Cell84:505-507(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    19. 19.
      "Presentation of antigens by MHC class II molecules: getting the most out of them."
      Villadangos J.A.
      Mol. Immunol.38:329-346(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    20. 20.
      "MHC class II molecules on the move for successful antigen presentation."
      Rocha N. , Neefjes J.
      EMBO J.27:1-5(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    21. 21.
      "Autophagy in MHC class II presentation: sampling from within."
      Menendez-Benito V. , Neefjes J.
      Immunity26:1-3(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    22. 22.
      "MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation."
      De Gassart A. , Camosseto V. , Thibodeau J. , Ceppi M. , Catalan N. , Pierre P. , Gatti E.
      Proc. Natl. Acad. Sci. U.S.A.105:3491-3496(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBCELLULAR LOCATION
    23. 23.
      "MHC class II transport at a glance."
      Berger A.C. , Roche P.A.
      J. Cell Sci.122:1-4(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    24. 24.
      "CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract."
      Beswick E.J. , Reyes V.E.
      World J. Gastroenterol.15:2855-2861(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    25. 25.
      "The HLA-DRalpha chain is modified by polyubiquitination."
      Lapaque N. , Jahnke M. , Trowsdale J. , Kelly A.P.
      J. Biol. Chem.284:7007-7016(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: UBIQUITINATION AT LYS-244 BY MARCH1 AND MARCH8;MUTAGENESIS OF LYS-244;SUBCELLULAR LOCATION
    26. 26.
      "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
      Chen R. , Jiang X. , Sun D. , Han G. , Wang F. , Ye M. , Wang L. , Zou H.
      J. Proteome Res.8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-103 AND ASN-143
      tissue: Liver.
    27. 27.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    28. 28.
      "Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1."
      Brown J.H. , Jardetzky T.S. , Gorga J.C. , Stern L.J. , Urban R.G. , Strominger J.L. , Wiley D.C.
      Nature364:33-39(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 28-207
    29. 29.
      "Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide."
      Stern L.J. , Brown J.H. , Jardetzky T.J. , Gorga J.C. , Urban R.G. , Strominger J.L. , Wiley D.C.
      Nature368:215-221(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 28-207
    30. 30.
      "Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen."
      Jardetzky T.S. , Brown J.H. , Gorga J.C. , Stern L.J. , Urban R.G. , Chi Y.I. , Stauffacher C. , Strominger J.L. , Wiley D.C.
      Nature368:711-718(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF COMPLEX WITH SEB
    31. 31.
      "The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3."
      Ghosh P. , Amaya M. , Mellins E. , Wiley D.C.
      Nature378:457-462(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 30-205 OF HLA-DRA/HLA-DRB1 HETERODIMER IN COMPLEX WITH CD74 PEPTIDE (CLIP);SUBUNIT;GLYCOSYLATION AT ASN-103 AND ASN-143;DISULFIDE BOND
    32. 32.
      "X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II."
      Dessen A. , Lawrence C.M. , Cupo S. , Zaller D.M. , Wiley D.C.
      Immunity7:473-481(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF COMPLEX WITH PEPTIDE FROM COLLAGEN
    33. 33.
      "Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein."
      Smith K.J. , Pyrdol J. , Gauthier L. , Wiley D.C. , Wucherpfennig K.W.
      J. Exp. Med.188:1511-1520(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF COMPLEX WITH PEPTIDE FROM MYELIN BASIC PROTEIN
    34. 34.
      "Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins."
      Li Y. , Li H. , Martin R. , Mariuzza R.A.
      J. Mol. Biol.304:177-188(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 26-206 OF HLA-DRA/HLA-DRB5 HETERODIMER IN COMPLEX WITH MBP PEPTIDE;SUBUNIT
    35. 35.
      "Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II."
      Li Y. , Li H. , Dimasi N. , McCormick J.K. , Martin R. , Schuck P. , Schlievert P.M. , Mariuzza R.A.
      Immunity14:93-104(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 26-206 OF HLA-DRA/HLA-DRB5 HETERODIMER IN COMPLEX WITH MBP PEPTIDE AND STREPTOCOCCUS PYOGENES SPEC PEPTIDE;SUBUNIT;DISULFIDE BOND
    36. 36.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 26-207 OF HLA-DRA/HLA-DRB5 HETERODIMER IN COMPLEX EPSTEIN-BARR VIRUS BALF5 PEPTIDE;SUBUNIT;DISULFIDE BOND
    37. 37.
      "Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule."
      Li Y. , Huang Y. , Lue J. , Quandt J.A. , Martin R. , Mariuzza R.A.
      EMBO J.24:2968-2979(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 26-206 OF HLA-DRA/HLA-DRB5 HETERODIMER IN COMPLEX WITH MBP PEPTIDE AND TRAC;SUBUNIT;DISULFIDE BOND
    38. 38.
      "Crystallographic structure of the human leukocyte antigen DRA, DRB3*0101: models of a directional alloimmune response and autoimmunity."
      Parry C.S. , Gorski J. , Stern L.J.
      J. Mol. Biol.371:435-446(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 26-207 OF HLA-DRA/HLA-DRB3 HETERODIMER IN COMPLEX WITH ITGB3 PEPTIDE (ALLOANTIGEN HPA-1A);SUBUNIT;DISULFIDE BOND
    39. 39.
      "The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles."
      Dai S. , Crawford F. , Marrack P. , Kappler J.W.
      Proc. Natl. Acad. Sci. U.S.A.105:11893-11897(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 26-206 OF HLA-DRA/HLA-DRB3 HETERODIMER IN COMPLEX WITH EEF1A2 PEPTIDE
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter